A little ASX company, FLC, is well ahead of the poms with similar technology. It’s already producing equipment and has made quite a few desalination sales around Europe & China (which is something i thought CLQ would be doing)
http://imagesignal.commsec.com.au/d...nZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZmRlbGF5ZWQuanNw
From FLC forum:
Here is what has happened since 30 June 2018, and my projections of how much revenue it will generate in the second half of 2018.
I am assuming US$0.4m per CMABR unit.
4/7/18 US$1.6m --> Four Aspiral units in China for Baiceng
6/7/18 US$0.4m--> One pilot unit in China for iTest
16/7/18 US$1.5m --> Three Nirobox units - BOOT, Bahamas (will be able to recognise upfront revenue on capex)
7/8/18 US$0.4m --> Aspiral WaterFleet US sale, pilot unit
9/8/18 US$1.5m --> Argentina water treatment plant, Jun19 commissioning (US$3.5m total contract value)
16/8/18 US$0.8m --> Two Aspiral units, Phillipines
1/10/18 US$7.2m --> San Quintin (US$48m capex over 20 months)
12/10/18 US$3.75m --> Aspiral, iTest China (US$45m over 3 years)
15/10/18 US$0.4m --> Aspiral, MABR module sales in US
So that is an estimated US$17.6m of revenue to be recognised based on contract wins since 30 June 2018.
CLQ Price at posting:
45.5¢ Sentiment: Hold Disclosure: Held
